stu wrote:Hi .
Avastin is not coming back any time soon for Colorectal patients ...
"... [The NICE] appraisals are based primarily on evaluations of efficacy and cost-effectiveness in various circumstances..."
Reference: https://en.m.wikipedia.org/wiki/National_Institute_for_Health_and_Care_Excellence
"Keytruda will be an expensive treatment option ... Merck has disclosed that its new PD-1 inhibitor will cost payers $12,500 per month or about $150,000 per year.... . Keytruda now looks set to become a blockbuster drug for Merck and a leading drug within the PD-1 inhibitor class..."
stu wrote:I help out at a cancer charity and it pains me to see people running out of treatment options yet when I start to ask about it , all I see is total confusion .
Return to “Colon Talk - Colon cancer (colorectal cancer) support forum”
Users browsing this forum: Google [Bot] and 151 guests